Most RIT strategies for malignant gliomas were administered locally into the postsurgical cavity or intratumorally and the first results on the local administration of [213Bi]Bi-substance P and [225Ac]Ac-substance P are promising [511,512,513,514]. The gene discussed is TAC1; the disease is malignant glioma.